1 year return (CAGR)
-39.18%
Grace Therapeutics, Inc. Exchange (NASDAQ, USD)
GRCE
1.94
-0.07 (-3.48%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-6.85%
5 year return (CAGR)
-28.50%
10 year return (CAGR)
-30.56%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
40.81M
Price/Sales
-
Ent value
28.92M
Price/Book
0.85
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-43.17%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.99 |
| Daily high | 2.05 |
| Daily low | 1.88 |
| Daily Volume | 76K |
| All-time high | 1953.60 |
| 1y analyst estimate | 5.86 |
| Beta | 0.44 |
| EPS (TTM) | -1.24 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GRCE | S&P500 | |
| Current price drop from All-time high | -99.90% | -3.00% |
| Highest price drop | -99.91% | -56.47% |
| Date of highest drop | 22 Sep 2023 | 9 Mar 2009 |
| Avg drop from high | -85.98% | -10.65% |
| Avg time to new high | 50 days | 12 days |
| Max time to new high | 3330 days | 1805 days |
News
